Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial (Q74453880)
Jump to navigation
Jump to search
scientific article published on 01 September 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial |
scientific article published on 01 September 2001 |
Statements
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial (English)
E Stadtmauer
A K Stewart
R Vescio
G Schiller
O Ballester
S Noga
H Rugo
C Freytes
S Tarantolo
F Sahebi
P Stiff
J Meharchard
R Schlossman
R Brown
H Tully
M Benyunes
C Jacobs
R Berenson
M White
J DiPersio
K C Anderson
1 September 2001